share_log

Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Technology Officer Tyagarajan Seshu

SEC announcement ·  Nov 28, 2023 16:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more